INTERNATIONAL PATENT: F. HOFFMANN-LA ROCHE AG, HOFFMANN-LA ROCHE INC. FILES APPLICATION FOR "USE OF FAP-CD40 BISPECIFIC ANTIBODY FOR THE MODULATION OF THE TUMOR MICROENVIRONMENT"

GENEVA, March 17 -- F. HOFFMANN-LA ROCHE AG (Grenzacherstrasse 1244070 Basel), HOFFMANN-LA ROCHE INC. (Overlook at Great Notch, 150 Clove Road8th Floor, Suite 8 - Legal DepartmentLittle Falls, New Jersey 07424) filed a patent application (PCT/EP2025/075017) for "USE OF FAP-CD40 BISPECIFIC ANTIBODY FOR THE MODULATION OF THE TUMOR MICROENVIRONMENT" on Sep 03, 2025. With publication no. WO/2026/052650, the details related to the patent application was published on Mar 12, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HAFTMANN, Claudia (c/o Roche Glycart AGWagistrasse 108952 Schlieren), RIEDER...